About this trial
This is a single center, prospective, observational study to explore and evaluate the differences on cognitive function and brain function by functional-MRI in autonomous cortisol secretion patients, and the different treatments methods on the cognitive function and brain function in patients with autonomous cortisol secretion
Eligibility criteria
This trial accepts healthy volunteersQualifiers
age 20-65 years;
≥ 6 years of education;
right-handed;
complete entire cognitive function tests;
Disqualifiers
< 6 years of education;
age < 20 years or > 65 years;
maximum diameter of AI <1cm;
active malignancies;
Trial population
autonomous cortisol secretion and non-functioning adrenal adenomas patients
Trial design
Cohort
Prospective
Treatments tested in this trial
Cognitive function assessment; functional magnetic resonance imaging
Behavioralcognitive function measurement
laparoscopic adrenal surgery
Procedure/SurgeryOnly a subgroup of the autonomous cortisol secretion patients will have the laparoscopic adrenal surgery
Treatment groups
Trial outcomes
Primary outcomes
Participants' personal information
Self-reported information(education in years)
Physical assessments
BMI(body mess index) in kg/m\^2
Imaging examinations
Adrenal adenoma size in cm
Montreal Cognitive Assessment (MoCA)
The MoCA is a Global cognitive screening test designed to assist Health Professionals in detection of mild cognitive impairment.
Secondary outcomes
Changes from basline global cognitive functions
MoCA
Changes from basline multiple cognitive subdomains
RBANS
Change from baseline Functional magnetic resonance imagine
Rs-fMRI
Changes from basline global cognitive functions
MoCA
Sponsors and contacts
Click on the lead sponsor to view all of their trials.